Viewing Study NCT00017550


Ignite Creation Date: 2025-12-24 @ 4:54 PM
Ignite Modification Date: 2026-01-25 @ 2:45 AM
Study NCT ID: NCT00017550
Status: COMPLETED
Last Update Posted: 2021-01-27
First Post: 2001-06-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
Sponsor: Genzyme, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None refractory anemia View
None refractory anemia with excess blasts View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View